These effects, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the thought of focusing on ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant Ailments. Based on offered science https://bobc703eay3.luwebs.com/profile